Beryl Drugs Limited (BOM:524606)

India flag India · Delayed Price · Currency is INR
20.35
+1.73 (9.29%)
At close: Mar 10, 2026
-22.15%
Market Cap 103.21M
Revenue (ttm) 176.65M
Net Income (ttm) 141.00K
Shares Out 5.07M
EPS (ttm) 0.03
PE Ratio 731.98
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 40,205
Average Volume 3,382
Open 18.71
Previous Close 18.62
Day's Range 17.06 - 22.34
52-Week Range 15.92 - 30.00
Beta -0.08
RSI 40.63
Earnings Date Feb 9, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524606
Full Company Profile

Financial Performance

In fiscal year 2025, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.

Financial Statements

News

There is no news available yet.